Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant progress in understanding the etiology and development of treatment strategies, IBD remain incurable for thousands of pat...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca7f68fc3d274d98b14d5ea15fe7cb46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ca7f68fc3d274d98b14d5ea15fe7cb46 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ca7f68fc3d274d98b14d5ea15fe7cb462021-11-11T17:08:42ZFat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases10.3390/ijms2221116821422-00671661-6596https://doaj.org/article/ca7f68fc3d274d98b14d5ea15fe7cb462021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11682https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant progress in understanding the etiology and development of treatment strategies, IBD remain incurable for thousands of patients. Metabolic deregulation is indicative of IBD, including substantial shifts in lipid metabolism. Recent data showed that changes in some phospholipids are very common in IBD patients. For instance, phosphatidylcholine (PC)/phosphatidylethanolamine (PE) and lysophosphatidylcholine (LPC)/PC ratios are associated with the severity of the inflammatory process. Composition of phospholipids also changes upon IBD towards an increase in arachidonic acid and a decrease in linoleic and a-linolenic acid levels. Moreover, an increase in certain phospholipid metabolites, such as lysophosphatidylcholine, sphingosine-1-phosphate and ceramide, can result in enhanced intestinal inflammation, malignancy, apoptosis or necroptosis. Because some phospholipids are associated with pathogenesis of IBD, they may provide a basis for new strategies to treat IBD. Current attempts are aimed at controlling phospholipid and fatty acid levels through the diet or via pharmacological manipulation of lipid metabolism.Lidiya V. BoldyrevaMaryana V. MorozovaSnezhanna S. SaydakovaElena N. KozhevnikovaMDPI AGarticleIBDCrohn’s diseaseulcerative colitisphosphatidylcholinelysophosphatidylcholinephosphatidylethanolamineBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11682, p 11682 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
IBD Crohn’s disease ulcerative colitis phosphatidylcholine lysophosphatidylcholine phosphatidylethanolamine Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
IBD Crohn’s disease ulcerative colitis phosphatidylcholine lysophosphatidylcholine phosphatidylethanolamine Biology (General) QH301-705.5 Chemistry QD1-999 Lidiya V. Boldyreva Maryana V. Morozova Snezhanna S. Saydakova Elena N. Kozhevnikova Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases |
description |
Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant progress in understanding the etiology and development of treatment strategies, IBD remain incurable for thousands of patients. Metabolic deregulation is indicative of IBD, including substantial shifts in lipid metabolism. Recent data showed that changes in some phospholipids are very common in IBD patients. For instance, phosphatidylcholine (PC)/phosphatidylethanolamine (PE) and lysophosphatidylcholine (LPC)/PC ratios are associated with the severity of the inflammatory process. Composition of phospholipids also changes upon IBD towards an increase in arachidonic acid and a decrease in linoleic and a-linolenic acid levels. Moreover, an increase in certain phospholipid metabolites, such as lysophosphatidylcholine, sphingosine-1-phosphate and ceramide, can result in enhanced intestinal inflammation, malignancy, apoptosis or necroptosis. Because some phospholipids are associated with pathogenesis of IBD, they may provide a basis for new strategies to treat IBD. Current attempts are aimed at controlling phospholipid and fatty acid levels through the diet or via pharmacological manipulation of lipid metabolism. |
format |
article |
author |
Lidiya V. Boldyreva Maryana V. Morozova Snezhanna S. Saydakova Elena N. Kozhevnikova |
author_facet |
Lidiya V. Boldyreva Maryana V. Morozova Snezhanna S. Saydakova Elena N. Kozhevnikova |
author_sort |
Lidiya V. Boldyreva |
title |
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases |
title_short |
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases |
title_full |
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases |
title_fullStr |
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases |
title_full_unstemmed |
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases |
title_sort |
fat of the gut: epithelial phospholipids in inflammatory bowel diseases |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/ca7f68fc3d274d98b14d5ea15fe7cb46 |
work_keys_str_mv |
AT lidiyavboldyreva fatofthegutepithelialphospholipidsininflammatoryboweldiseases AT maryanavmorozova fatofthegutepithelialphospholipidsininflammatoryboweldiseases AT snezhannassaydakova fatofthegutepithelialphospholipidsininflammatoryboweldiseases AT elenankozhevnikova fatofthegutepithelialphospholipidsininflammatoryboweldiseases |
_version_ |
1718432203484954624 |